Skin flexibility

Skin flexibility" is **not a specific molecule or receptor**, but rather a *physical property* of the skin that reflects its ability to stretch and return to its original shape. This property is primarily determined by the composition and organization of structural proteins in the dermal extracellular matrix, especially **collagen** and **elastin**[1][2][4]. Collagen provides tensile strength, while elastin allows for elastic recoil. The balance between synthesis and degradation of these proteins—regulated by enzymes such as matrix metalloproteinases (MMPs)—underlies changes in skin flexibility with age or disease[2][4][8]. Loss of skin flexibility is a hallmark of aging and certain diseases. It results from decreased collagen/elastin synthesis, increased degradation via MMPs, oxidative stress from reactive oxygen species (ROS), chronic inflammation, cellular senescence in fibroblasts, and impaired signaling pathways such as TGF-beta/Smad[2][4][6][8]. External factors like UV exposure accelerate these processes ("photoaging")[2]. While "skin flexibility" itself is not a druggable target or biomarker, interventions aimed at improving it often focus on modulating collagen/elastin metabolism through topical agents (retinoids), energy-based devices (lasers), fillers (hyaluronic acid), antioxidants to reduce ROS damage, or inhibitors/modulators of MMP activity[4]. However, none directly target "skin flexibility" as an entity; instead they act on underlying molecular pathways. In summary: "Skin flexibility" describes a functional/mechanical attribute resulting from complex interactions among multiple molecules—primarily collagen and elastin—and their regulatory mechanisms. It should not be considered a canonical therapeutic target molecule or receptor[1][2].

Other names

Skin elasticitySkin supplenessCutaneous flexibility